CRLHealthcareLarge-Cap
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CRL insiders buying or selling?
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insiders reported 9 open-market buys ($5.1M) and 180 sells ($239.7M) across 189 Form 4 filings — a net selling position of $234.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 1, 2026)
Total Form 4 filings
189
SEC EDGAR
Insider filers
16
Insider buys (9)
$5.1M
Insider sells (180)
$239.7M
Insider sentiment
Net sellingNet insider flow of $234.6M in net selling.
Recent CRL insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | James C Foster | Director | Sale | 75.0K | $225.00 | $16.9M |
| Mar 4, 2026 | Joseph W Laplume | EVP, Corp Strategy & Develop | Purchase | 25 | $174.54 | $4.4K |
| Jan 20, 2026 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 400 | $163.72 | $65.5K |
| Aug 20, 2025 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 800 | $157.60 | $126.1K |
| Aug 8, 2025 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 400 | $150.04 | $60.0K |
| May 16, 2025 | George Massaro | Director | Sale | 140 | $137.57 | $19.3K |
| May 15, 2025 | George Massaro | Director | Sale | 140 | $140.74 | $19.7K |
| May 15, 2025 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 500 | $145.41 | $72.7K |
| Feb 21, 2025 | James C Foster | Chairman, President and CEO | Purchase | 6.1K | $165.01 | $1.0M |
| Feb 21, 2025 | Birgit Girshick | Corporate Executive VP & COO | Purchase | 1.5K | $164.63 | $249.2K |
| Feb 21, 2025 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 4.4K | $162.50 | $715.0K |
| Nov 12, 2024 | Richard F Wallman | Director | Sale | 7.6K | $216.17 | $1.6M |
| Aug 12, 2024 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 1.8K | $199.36 | $354.9K |
| Aug 5, 2024 | James C Foster | Chairman, President and CEO | Sale | 25.0K | $250.00 | $6.3M |
| May 29, 2024 | Michael Gunnar Knell | CSVP&Chief Accounting Officer | Sale | 808 | $267.52 | $216.2K |
| May 16, 2024 | George Massaro | Director | Sale | 332 | $235.62 | $78.2K |
| May 14, 2024 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 1.3K | $226.97 | $296.0K |
| Mar 11, 2024 | Michael Gunnar Knell | CSVP&Chief Accounting Officer | Sale | 808 | $267.52 | $216.2K |
| Mar 5, 2024 | Michael Gunnar Knell | CSVP&Chief Accounting Officer | Sale | 2.8K | $261.05 | $717.9K |
| Mar 4, 2024 | Shannon M Parisotto | CEVP, Disc & Safety Assessment | Sale | 3.8K | $253.45 | $959.5K |
| Mar 1, 2024 | Victoria L Creamer | EVP & Chief People Officer | Sale | 5.0K | $253.70 | $1.3M |
| Feb 23, 2024 | William D Barbo | Corporate Executive VP & CCO | Sale | 4.0K | $248.50 | $1.0M |
| Feb 20, 2024 | Shannon M Parisotto | CEVP, Disc & Safety Assessment | Sale | 5.9K | $241.20 | $1.4M |
| Feb 20, 2024 | Joseph W Laplume | EVP, Corp Strategy & Develop | Sale | 838 | $238.93 | $200.2K |
| Dec 18, 2023 | Victoria L Creamer | EVP & Chief People Officer | Sale | 5.5K | $225.00 | $1.2M |
Showing the 25 most recent of 189 Form 4 filings for CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
Most active CRL insiders
- James C Foster56 filings
- Joseph W Laplume26 filings
- David Ross Smith22 filings
- Birgit Girshick15 filings
- George Massaro15 filings
Ask anything about CRL insider activity
Use Trabud's AI agent to query CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s Form 4 history in plain English — "Show me CRL CEO purchases this year" or compare it against any other ticker.
Open the AI agentCRL insider trading FAQ
Are CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insiders buying or selling?
Across 189 SEC Form 4 filings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) insiders reported 9 open-market purchases totaling $5.1M and 180 sales totaling $239.7M. That is a net selling position of $234.6M.
How many insiders trade CRL stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. The most recent filing was accepted on Jul 1, 2026.
Where does Trabud get CRL insider trading data?
All CRL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.